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Shift in the Sexes
Are Endocrine Disruptors Changing Birth Ratios?
According to demographic data compiled by the United Nations,
an average of 105 boys are born for every 100 girls. The male pro-
portion of births, equal to 0.515, varies slightly between years and
populations, but these factors do not fully explain consistently
shifting ratios in several industrialized countries over recent
decades. A new study examines birth and fetal death sex ratios in
Japan and the United States and reveals significant male-to-female
shifts in both nations [EHP 115:941–946; Davis et al.]. 
The research team calculated birth and fetal death sex ratios in
Japan based on 1949–1999 data from the Japanese Vital Statistics
Bureau. The proportion of male births varied yearly before 1970 but
declined steadily since then, from 0.5172 to 0.5135. Between 1960
and 1999, the male proportion of fetal deaths increased from 56%
to 67.7%. The male fetal death rate is approximately four times
higher in Japan than in the United States. 
For U.S. calculations, the researchers drew 1983–1995 fetal
death data and 1970–2002 birth data from the National Center for
Health Statistics. The proportion of male births dropped in the
United States, from 0.5134 in 1970 to 0.5117 in 2002. There are
significant racial differences, however: between 1970 and 2002 the
proportion of non-Hispanic white male births fell from 0.5143 to
0.5122, whereas the proportion of black male births rose slightly
from 0.5076 to 0.5079. The male proportion of black fetal deaths
also increased, rising from 53.5% to 54.5%; among whites, the male
proportion of fetal deaths rose by less than 0.5%.
Why birth sex ratios differ so much between white and black
women is unknown, but hormonal differences due to race and to
incidence of obesity may be involved. A possible explanation for
the increased ratio among black births may stem from improved
prenatal and obstetric care in general, reducing the overall number
of fetal deaths. 
The researchers speculate that parental exposures to endocrine-
disrupting chemicals, including metalloestrogens such as
methylmercury, might be factors undermining the conception and
survival of male children. They suggest particular scrutiny of
Japanese body burden of mercury and other metalloestrogens to
understand this difference. Additionally, future investigations of
declining sex ratios should consider the types and timing of prenatal
and parental exposures to endocrine-disrupting chemicals. The
researchers hypothesize that paternal exposures prior to conception
might affect expression of the SRY gene on the Y chromosome.
–Julia R. Barrett
Phthalates and Metabolism
Exposure Correlates with Obesity and 
Diabetes in Men
The prevalence of obesity, insulin resistance, and diabetes has increased
considerably in the past few decades. Many plausible contributing
factors have been identified for this increase, among them low testos-
terone levels in men. Research has found that exposure to certain
synthetic chemicals adversely affects testicular function in animals and
possibly in humans. A new analysis looked for—and found—that
exposure to one class of these chemicals, phthalates, correlated with
two metabolic abnormalities in men: abdominal obesity and insulin
resistance [EHP 115:876–882; Stahlhut et al.]. 
Phthalates are commonly used in products such
as cosmetics, soaps, pesticides, lubricants, plastics,
and paints. They are widespread; indeed, more
than 75% of the U.S. population carries detectable
levels of several phthalate metabolites. Studies have
also found associations between some phthalate
metabolites and antiandrogenic effects in humans,
including both infant and adult males.
The authors used 1999–2002 data from the
CDC National Health and Nutrition Examination
Survey (NHANES) to look for a connection
between phthalate exposure and metabolic disease in
adult men. They compared urine concentrations of
six phthalate metabolites to the participants’ waist
circumference and measures of insulin resistance.
The analysis controlled for a variety of potential con-
founders, including age, ethnicity, fat and calorie
consumption, physical activity, and smoking status.
Four phthalate metabolites were significantly associated with
greater waist circumference and three with increased insulin resis-
tance. When the authors further controlled their models for measures
of participants’ kidney and liver function, the associations decreased
somewhat but remained significant for all but one metabolite.  
The authors caution that this first look at phthalates, obesity, and
insulin resistance is limited by the study’s cross-sectional design and
the single measurement of urine phthalate metabolites (an imperfect
measure of long-term exposure). In addition, although the study was
based on the hypothesis that phthalates cause metabolic abnormali-
ties by decreasing androgen levels or function, the authors couldn’t
examine this mechanism, because the NHANES data do not contain
measures of sex hormones in men. They
note that other mechanisms could also be
involved in a relationship between phtha-
lates and metabolic disease. 
If phthalates are eventually shown con-
clusively to contribute to obesity or dia-
betes in men, it’s still not clear how these
chemicals would affect the opposite sex,
since low testosterone has been associated
with a lower (not higher) prevalence of
metabolic disease in women. If further
longitudinal studies confirm that phthalate
exposure contributes to obesity, diabetes,
and related disorders, actions to reduce
phthalate exposure could effectively lessen
the chemicals’ contribution to metabolic
disorders, because phthalates are quickly
metabolized and excreted by the body.
–Melissa Lee PhillipsChildhood Leukemia
in Germany
Cluster Identified near Nuclear
Power Plant
Childhood leukemia clusters have been
observed at a number of sites near European
nuclear facilities. With the identification of
the largest cluster to date, a new German study
underscores the need to clarify the association
[EHP 115:947–952; Hoffmann et al.]. 
Between February 1990 and May 1991,
five cases of leukemia were diagnosed in chil-
dren living within 5 kilometers of the
Krümmel nuclear power plant in Geesthacht
and a neighboring nuclear research operation
along the Elbe River in northern Germany. By
2005, another nine cases of leukemia had been
discovered in the area. Most of the cases were
acute lymphatic leukemia in males under five
years of age. 
Several expert commissions investigated,
and found moderate levels of cesium in rain-
water and air samples, along with plutonium
and americium in household dust near the plant. There was also
some evidence of chromosomal damage to lymphocytes among the
local population. One panel deemed these observations consistent
with fallout from a possible accident at the research facility that
would have to have occurred around September 1986, but so far no
such accident has been proved. Another panel suggested instead
that chance or population mixing—the
commingling of local people with newcom-
ers from various places—might have caused
the cluster.
In the current study, researchers com-
pared the number of observed leukemia cases
in the sparsely populated Geesthacht area to
the number of predicted cases based on near-
by county and national incidence rates from
1990 to 2005. The five cases found in 1990
and 1991 significantly exceeded the expected
incidence for that period of 0.45 cases. After
studying medical records from all treatment
facilities in the vicinity and in Hamburg, the
team concluded that the Geesthacht cluster is
the “largest series of childhood leukemia
cases reported to date” among European
leukemia clusters near nuclear facilities,
including those at Dounreay, Scotland;
LeHague, France; and Sellafield, England.
The authors state that population mixing
is unlikely to account for the leukemia inci-
dence because the population remained sta-
ble over the years studied. Nor would an
alleged one-time release of radiation in 1986
readily explain the cluster, given that the excess incidence persisted
over at least 15 years. Thus, they conclude, the elevated incidence of
childhood leukemia around Geesthacht remains “another piece in a
growing puzzle” of childhood leukemia’s association with nuclear
installations—and its severity and persistence emphasize the need to
keep investigating. –Valerie J. Brown
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A Twist in the Ritalin Riddle
Drug-Related Genomic Damage Not
Confirmed in Children
The frequently prescribed central nervous system stimulant
methylphenidate (MPH), better known by brand names that
include Ritalin, does not cause genomic damage in children, con-
trary to earlier reports, according to new work published this
month [EHP 115:936–940; Walitza et al.]. In use for more than
50 years and now prescribed more than 5 million times a year in
the United States, MPH is the drug of choice for attention
deficit/hyperactivity disorder (ADHD). ADHD is the most fre-
quently diagnosed psychiatric disorder in children
and adolescents, with an estimated 6–12% of
minors worldwide thus diagnosed. 
A 2005 report published in Cancer Letters
had showed that gross genomic damage—reflected
by chromosome aberrations including sister
chromatid exchanges and formation of micronu-
clei (smaller-than-normal cell nuclei containing
partial genomes)—was found in nucleated lym-
phocytes taken from peripheral circulation of
children who had been taking the drug for only
three months. Because large chromosomal breaks
are associated with cancer, the study raised con-
cerns about the potential for cancer risk in the
millions of people who have taken the stimulant. 
That 2005 study found an increased frequency
of chromosomal abnormalities in all of the 12
children whose lymphocytes were examined,
lending urgency to future studies. The current study looked at
micronuclei as an indicator of genomic damage in the lymphocytes
of 38 children newly prescribed the drug, following some but not
all of them out to six months. 
The children, 29 boys and 9 girls, took a variety of doses and
formulations of the drug. Some subjects were lost to follow-up
during the study; others switched to other medications or dropped
out because they did not respond to the drug. Eight children
stayed in the study through the whole six months. 
Overall, there was no significant increase in the formation of
micronuclei at any time point, though some individual children
had elevated numbers of micronucleated lymphocytes at one time
point or another. Further, the lympho-
cytes of 9 children who had been taking
the drug for more than six months at the
start of the study did not show increased
levels of micronucleation compared to the
pretreatment levels seen in drug-naïve
children. 
The marked difference in results
between the 2005 study and the current
one raises the possibility of unexplained
genetic differences between the study pop-
ulations. Whereas the first study popula-
tion included six white, four black, and two
Hispanic children, the latter study focused
on a more uniform group of ethnically
German children. The authors say further
work, especially on the long-terms effects of
MPH, is called for. –Victoria McGovern
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